SERPINF1 and cancer: According to Huang et al., PEDF inhibits the metastatic potential of lung cancer cells by increasing thrombospondin 1 release in cancer cell-derived exosomes, leading to suppressed cytoskeletal remodeling and exosome-induced lung cancer cell motility, migration, and invasion [113].